NTT-DATA
18.7.2024 14:01:34 CEST | Business Wire | Press release
NTT DATA, a leading IT infrastructure and services company, unveiled its new Edge AI platform to accelerate IT/OT convergence by bringing AI processing to the edge. By processing data when and where it is generated and unifying diverse IoT devices, systems and data, this unique, fully managed solution enables real-time decisions, enhanced operational efficiencies and secure AI application deployment across industries to drive advanced Industry 4.0 technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240718015818/en/
NTT DATA unveiled a new ultralight Edge AI platform, a fully managed service that allows enterprises to deploy AI applications at the edge using smaller, more efficient language learning models that deliver immediate AI insights. [Source: NTT DATA]
While the spotlight has been on GenAI and Large Language Models (LLMs), these technologies are impractical for industries requiring real-time and local decision-making. NTT DATA’s Edge AI solution addresses this challenge by processing massive data sets on compact computing platforms, using smaller, more efficient machine learning models to deliver real-time AI insights.
NTT DATA’s Edge AI is an all-inclusive managed service platform that includes all the systems, tools and capabilities required for AI at the edge. It addresses data discovery, collection, integration, computation power, seamless connectivity and AI model management.
The Edge AI platform, supported by NTT DATA’s consulting data scientists, managed services and global technical resources, addresses the shadow IoT challenge and AI infrastructure requirements. It does this by auto-discovering, unifying and processing data from IoT devices and IT assets across the organization, simplifying AI deployment and management.
Solving industry-specific challenges with AI-driven insights
Designed to support industry-specific requirements, the Edge AI platform leverages lighter, cost-effective AI models, enabling it to run within a small compute box. Edge AI will perform specific tasks, such as supporting safety or operational efficiency, by collecting data from disparate devices across a network environment, enabling instantaneous and secure data processing and analytics.
Manufacturing operations could benefit from improved predictive maintenance by accessing IT/OT data from sensors, machinery, cameras and applications to plan and address failures. In addition, NTT DATA’s Edge AI can monitor and optimize energy consumption in real time, predicting energy spikes and optimizing machine usage, reducing costs and CO2 emissions with renewable energy.
“Our Edge AI platform represents a significant leap forward in driving AI at the edge securely and cost-effectively,” said Shahid Ahmed, Group Executive Vice President of Edge Services at NTT DATA. “By harmonizing data from disparate sensors and devices with lightweight AI models, powering all kinds of automation use-cases, NTT DATA’s Edge AI is pioneering industrial AI adoption as the first fully managed offering, helping organizations modernize with tailored, industry-specific solutions.”
Seizing the US$200 billion market opportunity
According to IDC, worldwide spending on edge computing is expected to reach US$232 billion in 2024, an increase of 15% over 2023. This growth is perpetuated by the growing number of connected IoT devices worldwide, expected to exceed 41 billion by 2025.
NTT DATA is poised to capture significant market share through its dedicated IoT consulting and services business, which brings together 1,000 industry experts, hundreds of use cases from predictive maintenance, fleet management, connected factories, energy consumption monitoring and sustainability, and has already trained over 500 sales experts globally to accelerate its Edge AI go-to-market efforts.
NTT DATA’s Edge AI deployment approach allows clients to take advantage of a free 30-day discovery and diagnostic of their IT and OT environment. The software auto-discovers assets with its vast library of pre-built OT interfaces. After this initial stage, Edge AI software generates a comprehensive diagnostic report inventorying assets and data streams, including identifying security risks and vulnerabilities.
“A key challenge for enterprises is reliably capturing and aggregating operational data securely across a fragmented landscape of devices, platforms and data sources and turning it into actionable insights,” said Alejandro Cadenas, Associate Vice President, Telco Mobility & IoT Research, IDC Europe. “NTT DATA’s ultralight Edge AI addresses these issues and simplifies the deployment and adoption of a data-driven enterprise strategy, reducing risks and timelines and optimizing total cost of ownership and value for the enterprise."
Driving secure AI adoption at the edge with the first fully managed service
NTT DATA’s managed services for Edge AI offer a unified view and management of devices, sensors and assets. With expert support and advanced technologies, NTT DATA helps businesses simplify complex processes, drive cost savings, enhance performance and accelerate digital transformation.
As the industry’s first fully managed IT/OT convergence platform, Edge AI transforms physical assets into software assets for data-driven insights, regardless of the manufacturer. Operating at the edge, managed services integrate OT assets with IT applications, boosting operational efficiency. Edge AI also provides a view of the firmware version of all connected devices to promote vulnerability patching and overall device security.
“Computing and AI must happen where they create the most value for the enterprise; for many industrial enterprises this is where the data is generated. By ingesting IT and OT data and leveraging AI models to drive use-case specific results, the NTT DATA solution takes another step towards realizing the industry 4.0 vision,” said Pablo Tomasi, Principal Analyst, Private Network, Omdia. “Additionally, using task-specific small AI models will help drive AI democratization by making it is easier for the enterprise to introduce AI where and when is needed, without the need for an extensive overhaul of their whole infrastructure.”
Edge AI rounds out NTT DATA’s comprehensive Edge portfolio, which includes Enterprise IoT, Edge Compute, Private 5G and Device as a Service.
About NTT DATA
NTT DATA is a $30+ billion trusted global innovator of business and technology services. We serve 75% of the Fortune Global 100 and are committed to helping clients innovate, optimize and transform for long-term success. We invest over $3.6 billion each year in R&D to help organizations and society move confidently and sustainably into the digital future. As a Global Top Employer, we have diverse experts in more than 50 countries and a robust partner ecosystem of established and start-up companies. Our services include business and technology consulting, data and artificial intelligence, industry solutions, as well as the development, implementation and management of applications, infrastructure and connectivity. We are also one of the leading providers of digital and AI infrastructure in the world. NTT DATA is part of NTT Group and headquartered in Tokyo. Visit us at nttdata.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240718015818/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
